Buchumschlag

Expression of Transketolase like gene 1 (TKTL1) predicts disease-free survival in patients with locally advanced rectal cancer receiving neoadjuvant chemoradiotherapy

For patients with locally advanced rectal cancer (LARC) neoadjuvant chemoradiotherapy is recommended as standard therapy. So far, no predictive or prognostic molecular factors for patients undergoing multimodal treatment are established. Increased angiogenesis and altered tumour metabolism as adapti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Schwaab, Juliana (VerfasserIn) , Horisberger, Karoline (VerfasserIn) , Ströbel, Philipp (VerfasserIn) , Bohn, Beatrice (VerfasserIn) , Gencer, Deniz (VerfasserIn) , Kähler, Georg (VerfasserIn) , Kienle, Peter (VerfasserIn) , Post, Stefan (VerfasserIn) , Wenz, Frederik (VerfasserIn) , Hofmann, Wolf-Karsten (VerfasserIn) , Hofheinz, Ralf-Dieter (VerfasserIn) , Erben, Philipp (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 19 August 2011
In: BMC cancer
Year: 2011, Jahrgang: 11, Pages: 1-9
ISSN:1471-2407
DOI:10.1186/1471-2407-11-363
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1186/1471-2407-11-363
Volltext
Verfasserangaben:Juliana Schwaab, Karoline Horisberger, Philipp Ströbel, Beatrice Bohn, Deniz Gencer, Georg Kähler, Peter Kienle, Stefan Post, Frederik Wenz, Wolf-Karsten Hofmann, Ralf-Dieter Hofheinz and Philipp Erben
Beschreibung
Zusammenfassung:For patients with locally advanced rectal cancer (LARC) neoadjuvant chemoradiotherapy is recommended as standard therapy. So far, no predictive or prognostic molecular factors for patients undergoing multimodal treatment are established. Increased angiogenesis and altered tumour metabolism as adaption to hypoxic conditions in cancers play an important role in tumour progression and metastasis. Enhanced expression of Vascular-endothelial-growth-factor-receptor (VEGF-R) and Transketolase-like-1 (TKTL1) are related to hypoxic conditions in tumours. In search for potential prognostic molecular markers we investigated the expression of VEGFR-1, VEGFR-2 and TKTL1 in patients with LARC treated with neoadjuvant chemoradiotherapy and cetuximab.
Beschreibung:Gesehen am 28.10.2022
Beschreibung:Online Resource
ISSN:1471-2407
DOI:10.1186/1471-2407-11-363

Ähnliche Einträge